Send yourself the details of this trial and next steps
Please provide a valid email address.
Send yourself the details of this trial and next steps
Please provide a valid email address.
This doesn't look like a valid phone number. Please check.
Both First Name and Last Name are required. Please check.
Home»Breast cancer» Looking for patients with breast cancer who will be undergoing mastectomy to examine the incidence of chronic pain when Pulsed Electromagnetic Fields (PEMF) and Pectoral (PEC) Interfascial Blocks are used.
Clinical Trial
Looking for patients with breast cancer who will be undergoing mastectomy to examine the incidence of chronic pain when Pulsed Electromagnetic Fields (PEMF) and Pectoral (PEC) Interfascial Blocks are used.
This trial is examining the effectiveness of pulsed electromagnetic field (PEMF) or an anesthetic bupivacaine in lowering the incidence of chronic pain after surgery. The main outcome to be measured will be the incidence of chronic pain after each treatment. This study is being conducted in New York City.
The details
Chronic pain can occur after mastectomy, or breast tissue removal. Almost half of women experience this. Poor pain control can lead to a higher incidence of chronic pain and delayed wound healing. There are two methods of pain control during surgery, one that uses pulsed electromagnetic field (PEMF) and a device is placed over dressings at the surgical site. The second type is a pain block where a long lasting anesthetic bupivacaine is injected into the area. Both of these are effective but they have not been compared to each other in terms of effectiveness.
The main outcome to be measured in this study will be the incidence of chronic pain after pulsed electromagnetic field (PEMF) or an anesthetic bupivacaine. The secondary outcome is the quality of recovery.
Who are they looking for?
This study will recruit 60 women planning to undergo mastectomy.
Patients should not have a narcotic allergy or take chronic opioids before surgery.
How will it work
There will be four groups in this trial. Patients will be randomly allocated to 1) active PEMF and active bupivacaine, 2) active PEMF and placebo (substance with no active effect) drug, 3) placebo PEMF and bupivacaine or 4) placebo PEMF and placebo drug.
Pain scores and quality scores will be followed up via questionnaire for two years after surgery.
